Pacific Biosciences Of California reported $43.5M in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Accelerate Diagnostics AXDX:US USD 5.39M 88K
Agilent A:US USD 1.04B 28M
Bruker BRKR:US USD 749.5M 9.5M
Danaher DHR:US USD 3.11B 126M
Fluidigm FLDM:US USD 21.95M 845K
General Electric GE:US USD 17.4B 133M
Illumina ILMN:US USD 559M 41M
Myriad Genetics MYGN:US USD 19.6M 4.2M
Nanostring Technologies NSTG:US USD 45.76M 4.24M
Pacific Biosciences Of California PACB:US USD 43.5M 7.37M
Perkinelmer PKI:US USD 378.26M 246.04M
Quidel QDEL:US USD 536.2M 16.5M
Roche Holding ROG:VX 8.29B 577M
Thermo Fisher Scientific TMO:US USD 5.72B 54M
Waters WAT:US USD 442.24M 32.31M